Testing an experimental drug for high cholesterol
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your body mass index (BMI) must be 18 or higher.
- You must have either a history of artery disease (like heart attack or stroke) with LDL cholesterol at least 1.8 mmol/L, OR have intermediate/high risk for artery disease with LDL at least 2.6 mmol/L.
- You must agree to use effective birth control if you or your partner could become pregnant.
- You cannot have very high triglycerides (above 5.6 mmol/L) or certain other conditions (like recent heart event, severe heart failure, cancer within 5 years, or poorly controlled diabetes/high blood pressure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This study tests a new medicine called HS-10582 to see if it is safe and how well it works in people with mildly high LDL cholesterol (the 'bad' cholesterol). It may help lower cholesterol levels and could be a future treatment option.
This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.